Bala M, McLeod LD. Estimating minimally important difference: is it really minimal? Presented at the 2005 ISPOR 10th Annual International Meeting; May 2005.
Khan SB, Tam I, Clark D. AMCP format for formulary submissions: perspectives on dossier preparation and review: experiences shared. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC.
Zhang M, Anastassopoulos K, Hutchison R, Olson W, Goss T, Hewitt D, Gargiulo K, Siccardi M, Mordin MM. Summary of hospital logistics associated with intravenous patient-controlled analgesia (IV-PCA) for acute postoperative pain management. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC.
Tafesse E, Claxton A, Granger AL, Sanders J, Apelian D, Atillasoy E, Iloeje U. Estimates of health care costs for lamivudine-refractory chronic hepatitis b (CHB) patients. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):310.
Mansfield CA, Van Houtven GL, Johnson FR, Yang J. Do parents respond to ozone conditions? A comparison of children who have asthma and those who do not. Presented at the Environmental Protection Agency Science Forum; May 2005. Washington, DC.
Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005 May 1;161(9):891-8.
Meads DM, McKenna SP, Doward LC, Hampson N. Interpreting scores on the Quality of Life Index for Atopic Dermatitis (QoLIAD). Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):331-2.
Ettinger B, Earnshaw SR, Brogan AJ, Graham CN, Amonkar MM, Baran R. Modeled cost impact of persistence with bisphosphonate therapy for women with postmenopausal osteoporosis. Poster presented at the Academy of Managed Care Pharmacy 17th Annual Meeting & Showcase; April 23, 2005.
Yost KJ, Yount SE, Eton DT, Silberman C, Broughton-Heyes A, Cella D. Validation of the Functional assessment of cancer therapy-Breast Symptom Index (FBSI). Breast Cancer Res Treat. 2005 Apr 1;90(3):295-8.
Earnshaw SR, Patel P, Candrilli SD, Graham CN, Deplatchett J. Impact of treatment on exacerbations in pediatric asthma in managed care organizations. Poster presented at the 2005 AMCP 17th Annual Meeting & Showcase; April 2005.
Earnshaw SR, Pankaj PA, Candrilli SD, DePlatchett J, Graham CN, Williams L. Impact of pediatric asthma treatment on managed care organization budget. Poster presented at the 2005 AMCP 17th Annual Meeting & Showcase; April 1, 2005.
Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Antidepressant medication use for and risk of ovarian cancer. Obstet Gynecol. 2005 Apr 1;105(4):725-30.
Khan SB, Tam I, Clark D. Amcp dossiers: experiences shared. Poster presented at the 17th Annual Meeting and Showcase of the Academy of Managed Care Pharmacy; April 2005.
Midkiff KD. The endpoint verification internal computerized tracking system for the national lung screening trial. Poster presented at the Endpoint Verification Committee Meeting; April 2005.
Midkiff KD. The endpoint verification process (death review) for the national lung screening trial. Poster presented at the Bi-Annual Meeting of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Steering Committee; April 2005. Bethesda, MD.
Cuffee J, Hallfors D, Waller M, Vanderpuije A. Adolescent's perceptions of sexual intercourse and movement to first sexual experience. Poster presented at the Annual Meeting of the Society for Research in Child Development; April 2005.
Earnshaw SR, Brogan AJ, Graham CN, Amonkar MM, Baran R, Hebborn A. The impact of persistency on economic models for bisphosphonate therapy in osteoporosis. Poster presented at the 5th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis; March 26, 2005. Rome, Italy.
Morlock R, Williams VS, Feltner D, Cappelleri JC, Brock J, Endicott J. Evaluation of the daily assessment of symptoms – anxiety (DAS-A) questionnaire in patients with generalized anxiety disorder. Poster presented at the Annual Conference of the Anxiety Disorders Association of America; March 2005.
Yost KJ, Sorenson MV, Hahn EA, Glendenning GA, Gnanasakthy A, Cella D. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument. Value Health. 2005 Mar;8(2):117-27.
Richter A, Pladevall M, Manjunath R, Lafata JE, Xi H, Simpkins J, Brar I, Markowitz N, Iloeje U, Irish W. Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study. HIV Med. 2005 Mar 1;6(2):79-90.
DiBenedetti DB, Russell J, Davidson J, Katzman M, Marciniak M, Yurgin N. Measuring the burden of generalized anxiety disorder in North America. Poster presented at the 25th Anxiety Disorders Association of America Annual Conference; March 2005.
DiBenedetti DB, Russell J, Jacobi F, Yurgin N, Davidson J, Katzman M. Measuring the global burden of generalized anxiety disorder (GAD). Poster presented at the 25th Anxiety Disorders Association of America Annual Conference; March 2005.
Reed SD, Anstrom KJ, Bakhai A, Briggs AH, Califf RM, Cohen DJ, Drummond MF, Glick HA, Gnanasakthy A, Hlatky MA, O'Brien BJ, Torti FMJr, Tsiatis AA, Wilan AR, Mark DB, Schulman KA. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J. 2005 Mar;149(3):434-43.
Register TC, Cann JA, Kaplan JR, Williams JK, Adams MR, Morgan TM, Anthony MS, Blair RM, Wagner JD, Clarkson TB. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab. 2005 Mar;90(3):1734-40.
Pring CM, Skelding-Millar L, Goodall RJ. Expectant treatment or cholecystectomy after endoscopic retrograde cholangiopancreatography for choledocholithiasis in patients over 80 years old? Surg Endosc. 2005 Mar;19(3):357-60.
Johnson FR, Mansfield CA, Yang J. Noise, congestion, pollution, and great scenery: visitor preferences for winter management options at yellowstone national park. Presented at the W1133 Meetings; February 2005. Salt Lake City, UT.
Mauskopf JA, Earnshaw SR, Mullins C. Budget impact analysis: review of the state of the art. Expert Rev Pharmacoecon Outcomes Res. 2005 Feb;5(1):65-79.
McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, Baro E, Cook SA, Crickx B. International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res. 2005 Feb 1;14(1):231-41.
Manga N, Duffy JC, Rowe PH, Cronin MTD. Structure-based methods for the prediction of the dominant P450 enzyme in human drug biotransformation: consideration of CYP3A4, CYP2C9, CYP2D6. SAR QSAR Environ Res. 2005 Feb;16(1-2):43-61.
Bray JW, Davis KL, Graver L, Schroeder D, Buck JA, Dilonardo J, Vandivort R. Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 states. J Behav Health Serv Res. 2005 Jan 1;32(3):282-93.
Finkelstein EA, Ruhm C, Kosa KM. Economic causes and consequences of obesity. Annu Rev Public Health. 2005;26:239-57.
Whalley D, Bojke C, Gravelle H, Sibbald B. The new gms contract: a further blow to the waning satisfaction of the general practitioner? Poster presented at the National Primary Care Research and Development Centre; January 2005.
Rousu M, Kosa K. Allowing options in experimental auctions. Appl Econ Lett. 2005;12(13):817-21. doi: 10.1080/13504850500193059
Strickland A, Brogan AJ, Krauss J, Martindale R, Cresci G. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. J Parenter Enter Nutr. 2005 Jan 1;29(1 Suppl):S81-91.
Cvetkovski RS, Rothman KJ, Olsen J, Mathiesen B, Iversen L, Johansen JD, Agner T. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol. 2005 Jan 1;152(1):93-8.
Morgan L, Hawe E, Palmen J, Montgomery H, Humphries SE, Kitchen N. Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms. Br J Neurosurg. 2005;19(4):317-21.
Talmud PJ, Stephens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ, Humphries SE, Ordovas JM. The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet. 2005;69(6):613-22.
Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005 Jan 1;95(Suppl 1):S144-150.
Nielsen GL, Norgard B, Puho E, Rothman KJ, Sorensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med. 2005 Jan 1;22(6):693-6.
Fischer T, Johnsen SP, Pedersen L, Gaist D, Sorensen HT, Rothman KJ. Seasonal variation in hospitalization and case fatality of subarachnoid hemorrhage - A nationwide Danish study on 9,367 patients. Neuroepidemiology. 2005 Jan 1;24(1-2):32-7.
Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 Jan 1;142(5):323-32.
Johannes CB, Schneider GA, Dube TJ, Alfredson TD, Davis KJ, Walker AM. The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease. Chest. 2005 Jan 1;127(1):89-97.
Perez-Gutthann S. ISPE Commentary: twentieth annual conference on pharmacoepidemiology and therapeutic risk management. 2005.
Price MA. Standard-setting procedures report for the North Carolina checklist of academic standards (NCCLAS). 2005.
Price MA, Fiore T, Wilaby M. A study of the impact of schools attuned on special education services—phase two report. 2005.
Brogan AJ, Stidham S. A note on separation in mean-lower-partial-moment portfolio optimization with fixed and moving targets. IIE Trans. 2005 Jan 1;37(10):901-6.
Gaffney L, Sherrill EH, Wolowacz SE, Allen R, Connolly M. Predictors of health-related quality of life (HRQoL) in US patients suffering from rls. Poster presented at the International Congress on Parkinson's Disease and Movement Disorders; 2005.
Gaffney L, Sherrill B, Wolowacz SE, Allen R, Connolly M, Kirsch J. Evaluating the predictors of health-related quality of life in European respondents with restless legs syndrome. Poster presented at the ICPD meeting; 2005; 2005. Berlin, Germany.
Li P, Elrayess MA, Gomma AH, Palmen J, Hawe E, Fox KM, Humphries SE. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting. Chin Med J (Engl). 2005;118(18):1525-32.